# Risk Reduction for Alzheimer's Disease

Study · id `cardio:ct-nct02913664` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02913664](<https://clinicaltrials.gov/study/NCT02913664>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02913664

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 513 participants.

## Technical summary

Registry record NCT02913664. Randomized; single masking; primary purpose prevention. Start 2017-02-02 (actual); primary completion 2021-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 513 participants (enrolled count; ClinicalTrials.gov record NCT02913664, source copy `cardio:ctgov-nct02913664-2022-02-15`, retrieved 2026-10-26)
- Started: 2017-02-02 (actual) (ClinicalTrials.gov record NCT02913664, source copy `cardio:ctgov-nct02913664-2022-02-15`, retrieved 2026-10-26)
- Primary completion: 2021-11-30 (actual) (ClinicalTrials.gov record NCT02913664, source copy `cardio:ctgov-nct02913664-2022-02-15`, retrieved 2026-10-26)
- Completion: 2022-01-31 (actual) (ClinicalTrials.gov record NCT02913664, source copy `cardio:ctgov-nct02913664-2022-02-15`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02913664, source copy `cardio:ctgov-nct02913664-2022-02-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02913664-2022-02-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Risk Reduction for Alzheimer's Disease
- Acronym: rrAD
- Condition: Cognitively Normal Older Adults
- Condition: Hypertension
- Condition: Subjective Cognitive Decline
- Condition: Family History of Alzheimer's Disease
- Intervention (Drug): Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
- Intervention (Behavioral): Aerobic Exercise Training
- Intervention (Other): Usual Care
- Intervention (Behavioral): Stretching Exercise
- Lead sponsor: University of Texas Southwestern Medical Center
- Lead sponsor class: OTHER
- Collaborator: Texas Health Resources
- Collaborator class: OTHER
- Collaborator: University of Kansas Medical Center
- Collaborator class: OTHER
- Collaborator: Washington University School of Medicine
- Collaborator class: OTHER
- Collaborator: Pennington Biomedical Research Center
- Collaborator class: OTHER
- Collaborator: Michigan State University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: University of Texas Southwestern Medical Center (`cardio:org-university-of-texas-southwestern-medical-center`)
- Registry lists this organization as a collaborator: University of Kansas Medical Center (`cardio:org-university-of-kansas-medical-center`)
- Registry lists this organization as a collaborator: Washington University School of Medicine (`cardio:org-washington-university-school-of-medicine`)
- Registry lists this organization as a collaborator: Michigan State University (`cardio:org-michigan-state-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Exercise and Intensive Vascular Risk Reduction on Cognitive Function in Older Adults: A Randomized Clinical Trial (`cardio:pubmed-41870419`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 26824315d567ec6909525d0790cb815ff951fc6f0aa8a87a3f261fc53b005d14
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
